A Phase-Ii Study Based on Dose Adjustment According to UGT1A1 Polymorphism: is Irinotecan Underdosed in First-Line FOLFIRI Regimen for Mcrc?
CANCER CHEMOTHERAPY AND PHARMACOLOGY(2024)
Key words
Irinotecan,UGT1A1 polymorphism,Metastatic colorectal cancer,First-line treatment
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined